Equine Healthcare Market By Product Type (Drug Type, Vaccine Type,Supplements and Additives), By Disease Type (West Nile Virus, Equine Rabies, Potomac Horse Fever, Tetanus, Equine Influenza, Equine Herpes Virus)- Growth, Future Prospects & Competitive Analysis, 2018 - 2026

The global equine healthcare market was worth US$ 626.2 million in 2017 and is expected to expand at a compound annual growth rate (CAGR) of 4.0% from 2018 to 2026. The growing trend of horse breeding and leisure horse riding is a major growth factor in the equine healthcare market.

Other factors, such as the growing incidence of equine infections and the development of novel animal safety and health programs, will continue to assist the market's growth. Horse racing for gambling and leisure purposes is highly active in regions such as North America, Europe, and Asia Pacific, which stimulates the demand for equine healthcare products in the region.

The companies operating in the market are engaging in research and development of novel products to gain a competitive edge in the market.

Market Synopsis

drug segment to drive the global equine healthcare market

In 2017, the drugs segment held the largest share in the global equine healthcare market owing to a growing demand for therapeutic drugs for the treatment of various diseases. Horses are highly prone to diseases such as tetanus, equine encephalomyelitis, rabies, equine influenza, and West Nile virus, among others, which need to be taken care of.

The drugs segment is further segmented into anti-infective, anti-inflammatory, and anti-parasitic drugs. Vaccines held the second-largest market and are projected to grow at a steady rate during the forecast period. Supplements and additives are expected to exhibit the fastest growth rate due to high product launches and growing awareness regarding the benefits of supplements among equine caretakers.

Periods of History and Forecast

This research report presents the analysis of each segment from 2016 to 2026, considering 2017 as the base year for the research. The compound annual growth rate (CAGR) for each of the respective segments was calculated for the forecast period from 2018 to 2026.

Report Scope by Segments

The equine healthcare market report provides quantitative analysis as well as current market trends. The market is segmented based on product type, disease type, and geography.

The market is studied in order to understand the current dynamics and future trends in the global equine healthcare market. The study includes market size and forecasts for all considered segments presented in the report for the period from 2016 to 2026, along with respective compound annual growth rates (CAGRs) for the forecast period from 2018 to 2026, considering 2017 as the base year.

The key players currently engaged in the equine healthcare market include Zoetis, Bayer AG, Boehringer Ingelheim (Merial), Vetoquinol S.A., Purina Animal Nutrition LLC, and Merck & Co. (Merck Animal Health), among others.

Key questions are answered in this report.

  • How will the global equine healthcare market perform during the forecast period from 2018 to 2026?
  • What are the latest trends in the equine healthcare market and valuable opportunities for key players?
  • Who are the leading players in the global equine healthcare market?
  • Which is the leading and fastest-growing region in the global equine healthcare market?
  • What are the drivers and restraints governing the global equine healthcare market?

Frequently Asked Question:

The market for Equine Healthcare Market is expected to reach US$ 626.2 Mn in 2026.

The Equine Healthcare Market is expected to see significant CAGR growth over the coming years, at 4.0%.

The report is forecasted to 2018-2026.

The base year of this report is 2017.

International Business Machines (IBM) Corporation, Microsoft Corporation, Palantir Technologies Bayer AG, Boehringer Ingelheim (Merial), Vetoquinol S.A .are some of the major players in the global market.

Choose License Type
Trusted By
Published Date:  Jan 2019
Category:  Pharmaceuticals
Report ID:   59516
Report Format:   PDF
Pages:   120
Rating:    4.4 (69)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support